Cepham has announced the development of SheVari4, a patent-pending ingredient derived from Asparagus racemosus roots, known in Ayurveda as Shatavari.
Cepham (Somerset, NJ) has announced the development of SheVari4, a patent-pending ingredient derived from Asparagus racemosus roots, known in Ayurveda as Shatavari. The ingredient is for the support of women’s health.
"In our pursuit of an adaptogen tailored for women's self-care, I engaged in a meaningful dialogue with my mother, exploring the Ayurvedic remedies she and her mother relied on for well-being," said Anand Swaroop, PhD, founder and president of Cepham, in a press release. "Our goal was to pinpoint an adaptogen that addresses the nuanced spectrum of women's health concerns including hormone balance, mood support and focus. This inquiry that began with my mother, coupled with our extensive work on the phytochemistry of Shatavari, allowed us to identify the specific bioactive molecules responsible for its adaptogenic effects, culminating in the development of SheVari4."
"The research landscape for women's health is currently under-addressed and lacks science-backed ingredients," said Rena Cohen-First, vice president of sales at Cepham, in a press release. "Our in-house research, anchored in comprehensive data analysis, has unveiled a stark gap in understanding women's health. We are determined to bridge this void through our commitment to developing impactful, scientific solutions."
SheVari4 is standardized to shatavarin IV, a compound demonstrated to support women’s health needs. According to Cepham, the ingredient can be used to support women’s health concerns such as hot flashes, night sweats, brain fog, focus challenges, anxiety, low mood, irritability, and stress.